105
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Zuojin Pill inhibits the proliferation of esophageal cancer cells by inducing ROS production and apoptosis via regulation of PI3K/Akt signalling

, , , , , , & show all
Article: 2361991 | Received 18 Oct 2023, Accepted 25 May 2024, Published online: 14 Jun 2024

References

  • Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician. 2017 Jan 1;95(1):22–28. PMID: 28075104.
  • Watanabe M, Otake R, Kozuki R, et al. Recent progress in multidisciplinary treatment for patients with esophageal cancer. Surg Today. 2020 Jan;50(1):12–20. doi:10.1007/s00595-019-01878-7
  • Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7–33. doi:10.3322/caac.21708
  • Kato H, Nakajima M. Treatments for esophageal cancer: a review. Gen Thorac Cardiovasc Surg. 2013 Jun;61(6):330–335. doi:10.1007/s11748-013-0246-0
  • Yang X, Ren H, Guo X, et al. Radiation-induced skin injury: pathogenesis, treatment, and management. Aging (Albany NY). 2020 Nov 16;12(22):23379–23393. doi:10.18632/aging.103932
  • Guo W, Huang J, Wang N, et al. Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula zuojin pill in suppressing hepatocellular carcinoma. Front Pharmacol. 2019 Oct 9;10:1185, doi:10.3389/fphar.2019.01185
  • Wang N, Pei H, Xing LW. Natural regulatory T cells and bifunctional regulatory T cells: potential targets of traditional Chinese medicine in treating colitis-associated colon cancer. Integr Med Discov. 2024; 8:e24006. doi:10.53388/IMD202408006
  • Lu C, Ke L, Li J, et al. Chinese medicine as an adjunctive treatment for gastric cancer: methodological investigation of meta-analyses and evidence Map. Front Pharmacol. 2022 Jan 10;12:797753, doi:10.3389/fphar.2021.797753
  • Commission CP, Wan Z. The pharmacopoeia of the people’s republic of China. Beijing: China Medical Science Press; 2020, p. 802.
  • Zhao YL, Shi WL, Shan LM, et al. Differences in effects of Zuojin Pills and its similar formulas on Wei cold model in rats. Chin J Integr Med. 2009 Aug;15(4):293–298. doi:10.1007/s11655-009-0293-7
  • Huang S, Zhang Z, Li W, et al. Network pharmacology-based prediction and verification of the active ingredients and potential targets of Zuojinwan for treating colorectal cancer. Drug Des Devel Ther. 2020 Jul 14;14:2725–2740. doi:10.2147/DDDT.S250991
  • Wang K, Miao X, Kong F, et al. Integrating network pharmacology and experimental verification to explore the mechanism of effect of zuojin pills in pancreatic cancer treatment. Drug Des Devel Ther. 2021 Sep 4;15:3749–3764. doi:10.2147/DDDT.S323360
  • Li RL, Wang LY, Liu S, et al. Natural flavonoids derived from fruits are potential agents against atherosclerosis. Front Nutr. 2022 Mar 24;9:862277, doi:10.3389/fnut.2022.862277
  • Peng W, He CX, Li RL, et al. Zanthoxylum bungeanum amides ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK/Nrf2 signaling. J Ethnopharmacol. 2024 Jan 10;318(PtA):116848. doi:10.1016/j.jep.2023.116848
  • Li CJ, Ma XP, Nie H. Mechanism of Shenxiong glucose injection against myocardial ischemia-reperfusion injury based on network pharmacology and molecular docking. Zhongguo Zhong Yao Za Zhi. 2022 May;47(10):2759–2766. doi:10.19540/j.cnki.cjcmm.20211108.401
  • Wang Z, Li S. Network pharmacology in quality control of traditional Chinese medicines. Chin Herb Med. 2022 Sep;2022;14(4):477–478. doi:10.1016/j.chmed.2022.09.001
  • Wei Y, Ren S, Wang R, et al. Based on network pharmacology to explore the potential bioactive compounds and mechanisms of zuojin pill for the treatment of ulcerative colitis. Evid Based Complement Alternat Med. 2021 Aug 26;2021:7567025, doi:10.1155/2021/7567025
  • Jelic MD, Mandic AD, Maricic SM, et al. Oxidative stress and its role in cancer. J Cancer Res Ther. 2021 Jan-Mar;17(1):22–28. doi:10.4103/jcrt.JCRT_862_16
  • Hao M, Liu R. Molecular mechanism of CAT and SOD activity change under MPA-CdTe quantum dots induced oxidative stress in the mouse primary hepatocytes. Spectrochim Acta A Mol Biomol Spectrosc. 2019 ;220:117104, doi:10.1016/j.saa.2019.05.009
  • Behzadi R, Ahmadpour S, Amiri FT, et al. Choosing the right protocol to establish MCF-7 tumor xenograft in nude mice. Anticancer Agents Med Chem. 2023;23(2):222–226. doi:10.2174/1871520622666220517090735
  • Zhang Q, Chen WW, Sun X, et al. Hbo1 induces histone acetylation and is important for non-small cell lung cancer cell growth. Int J Biol Sci. 2022 May 16;18(8):3313–3323. doi:10.7150/ijbs.72526
  • Liu P, Xu H, Shi Y, et al. Potential molecular mechanisms of plantain in the treatment of gout and hyperuricemia based on network pharmacology. Evid Based Complement Alternat Med. 2020 Oct 22;2020:3023127, doi:10.1155/2020/3023127
  • Ru J, Li P, Wang J, et al. Tcmsp: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014 Apr 16;6:13, doi:10.1186/1758-2946-6-13
  • Gfeller D, Grosdidier A, Wirth M, et al. Swisstargetprediction: a web server for target prediction of bioactive small molecules. Nucleic Acids Res. 2014 Jul;42(Web Server issue):W32–W38. doi:10.1093/nar/gku293
  • Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Protoc Bioinformatics. 2016 Jun 20;54:1.30.1–1.30.33. doi:10.1002/cpbi.5
  • Peng W, Wu JG, Jiang YB, et al. Antitumor activity of 4-O-(2″-O-acetyl-6″-O-p-coumaroyl-β-D-glucopyranosyl)-p-coumaric acid against lung cancers via mitochondrial-mediated apoptosis. Chem Biol Interact. 2015 May 25;233:8–13. doi:10.1016/j.cbi.2015.03.014
  • Peng W, Hu C, Shu Z, et al. Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53. Phytomedicine. 2015 Jul 15;22(7-8):730–736. doi:10.1016/j.phymed.2015.05.003
  • Luo M, Zheng Y, Tang S, et al. Radical oxygen species: an important breakthrough point for botanical drugs to regulate oxidative stress and treat the disorder of glycolipid metabolism. Front Pharmacol. 2023 May 12;14:1166178, doi:10.3389/fphar.2023.1166178
  • Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY). 2016 Apr;8(4):603–619. doi:10.18632/aging.100934
  • Li RL, Zhang Q, Liu J, et al. Hydroxy-α-sanshool possesses protective potentials on H2O2-stimulated PC12 cells by suppression of oxidative stress-induced apoptosis through regulation of PI3 K/AKT signal pathway. Oxid Med Cell Longev. 2020 Jul 9;2020:3481758, doi:10.1155/2020/3481758
  • Yu L, Wei J, Liu P. Attacking the PI3 K/AKT/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69–94. doi:10.1016/j.semcancer.2021.06.019
  • Peng Y, Wang Y, Zhou C, et al. Pi3 K/AKT/mTOR pathway and its role in cancer therapeutics: are We making headway? Front Oncol. 2022;12:819128, doi:10.3389/fonc.2022.819128
  • Luo Q, Du R, Liu W, et al. Pi3 K/AKT/mTOR signaling pathway: role in esophageal squamous cell carcinoma, regulatory mechanisms and opportunities for targeted therapy. Front Oncol. 2022;12:852383, doi:10.3389/fonc.2022.852383